The translation of demonstrated diabetes and obesity treatments into practice has been slow, however, the resource burden of lifestyle treatments demonstrated in efficacy trials may be too great for patients, clinicians, and health care systems to sustain long-term (16). Translation of lifestyle efficacy trials into lower-intensity, cost-effective interventions is crucial to allow management of obese individuals with type 2 diabetes in practice and to maximize the applicability and long-term maintenance of interventions (17,18).